| Literature DB >> 28690497 |
Aljoscha Thomschewski1,2,3, Yvonne Höller1,3,4, Peter Höller1,2, Stefan Leis1,2, Eugen Trinka1,2,4.
Abstract
Recent advances in neuroprostheses provide us with promising ideas of how to improve the quality of life in people suffering from impaired motor functioning of upper and lower limbs. Especially for patients after spinal cord injury (SCI), futuristic devices that are controlled by thought via brain-computer interfaces (BCIs) might be of tremendous help in managing daily tasks and restoring at least some mobility. However, there are certain problems arising when trying to implement BCI technology especially in such a heterogenous patient group. A plethora of processes occurring after the injuries change the brain's structure as well as its functionality collectively referred to as neuroplasticity. These changes are very different between individuals, leading to an increasing interest to reveal the exact changes occurring after SCI. In this study we investigated event-related potentials (ERPs) derived from electroencephalography (EEG) signals recorded during the (attempted) execution and imagination of hand and foot movements in healthy subjects and patients with SCI. As ERPs and especially early components are of interest for BCI research we aimed to investigate differences between 22 healthy volunteers and 7 patients (mean age = 51.86, SD = 15.49) suffering from traumatic or non-traumatic SCI since 2-314 months (mean = 116,57, SD = 125,55). We aimed to explore differences in ERP responses as well as the general presence of component that might be of interest to further consider for incorporation into BCI research. In order to match the real-life situation of BCIs for controlling neuroprostheses, we worked on small trial numbers (<25), only. We obtained a focal potential over Pz in ten healthy participants but in none of the patients after lenient artifact rejection. The potential was characterized by a high amplitude, it correlated with the repeated movements (6 times in 6 s) and in nine subjects it significantly differed from a resting condition. Furthermore, there are strong arguments against possible confounding factors leading to the potential's appearance. This phenomenon, occurring when movements are repeatedly conducted, might represent a possible potential to be used in futuristic BCIs and further studies should try to investigate the replicability of its appearance.Entities:
Keywords: brain plasticity; electroencephalography; motor evoked potential; neuroplasticity; neuroprosthetics; spinal cord injury
Year: 2017 PMID: 28690497 PMCID: PMC5481367 DOI: 10.3389/fnins.2017.00362
Source DB: PubMed Journal: Front Neurosci ISSN: 1662-453X Impact factor: 5.152
Patients participating in the study.
| Patient 1 | 51 | D | C4 | 2 | Wheelchair |
| Patient 2 | 61 | C | C4 | 204 | Wheelchair |
| Patient 3 | 24 | C | C5 | 48 | Wheelchair |
| Patient 4 | 65 | C | C4 | 19 | Power wheelchair |
| Patient 5 | 44 | D | C6 | 216 | Wheelchair |
| Patient 6 | 48 | D | C7 | 314 | Wheelchair |
| Patient 7 | 70 | D | T8 | 13 | Wheelchair |
Figure 1Example sequence of an experimental trial.
Figure 2Example of an ERP of a healthy subject during the foot movement condition. On the top (A) a single trial response on Pz and the EMG with regard to stimulus onset (time point 0) is shown. The x-axes display time (ms) and the y-axes amplitudes (μV). On the bottom (B), activation maps of the averaged signal can be seen.
Number of included segments per condition after strict artifact exclusion (number of recorded segments if not 25).
| Patient 1 | 4 (50) | 7 (50) | 13 (50) | 13 (50) | 8 (50) | |
| Patient 2 | 0 (100) | 0 (100) | 0 (100) | 0 (100) | 0 (100) | |
| Patient 3 | 0 (64) | 0 (64) | 0 (64) | 0 (62) | 0 (64) | |
| Patient 4 | 20 (75) | 3 (75) | 22 (75) | 22 (75) | 17 (75) | |
| Patient 5 | 2 | 0 | 0 | 2 | 1 | |
| Patient 6 | 0 | 0 | 0 | 0 | 0 | |
| Patient 7 | 0 (24) | 1 | 0 | 0 | 0 | 1 |
| Control 1 | 1 | 1 | 0 | 0 | 0 | 0 |
| Control 2 | 0 | 2 | 4 | 7 | 10 | 7 |
| Control 3 | 0 | 0 | 0 | 1 | 0 | 2 |
| Control 4 | 0 (23) | 0 | 0 | 2 | 1 | 3 |
| Control 5 | 7 | 7 | 9 | 11 | 15 | 11 |
| Control 6 | 9 | 9 | 11 | 10 | 14 | 5 |
| Control 7 | 0 | 0 | 1 | 0 | 4 | 0 |
| Control 8 | 3 | 3 | 4 | 4 | 7 | 0 |
| Control 9 | 8 | 8 | 5 | 14 | 11 | 1 |
| Control 10 | 0 | 0 | 0 | 0 | 0 | 3 |
| Control 11 | 0 | 0 | 0 | 0 | 0 | 1 |
| Control 12 | 0 | 0 | 0 | 0 | 0 | 0 |
| Control 13 | 0 (24) | 0 | 0 | 0 | 0 | 0 |
| Control 14 | 1 | 0 | 0 | 1 | 1 | 2 |
| Control 15 | 9 | 9 | 13 | 17 | 19 | 13 |
| Control 16 | 1 | 1 | 0 | 0 | 1 | 0 |
| Control 17 | 0 | 0 | 0 | 1 | 0 | 1 |
| Control 18 | 8 | 8 | 8 | 10 | 12 | 7 |
| Control 19 | 1 | 1 | 0 | 5 | 8 | 9 |
| Control 20 | 0 | 0 | 0 | 0 | 0 | 0 |
| Control 21 | 0 (22) | 0 | 0 | 0 | 0 | 0 |
| Control 22 | 5 | 6 | 7 | 13 | 15 | 17 |
BEWG, foot movement locked to EMG; MFOT, foot movement locked to stimulus onset; MHND, hand movement; IFOT, foot movement imagination; IHND, hand movement imagination; REST, resting. Subjects with no included segments are not depicted.
Number of included segments per condition after lenient artifact exclusion (number of recorded segments if not 25).
| Patient 1 | 50 (50) | 50 (50) | 50 (50) | 50 (50) | 50 (50) | |
| Patient 2 | 99 (100) | 100 (100) | 100 (100) | 98 (100) | 98 (100) | |
| Patient 3 | 63 (64) | 63 (64) | 59 (64) | 61 (62) | 57 (64) | |
| Patient 4 | 75 (75) | 75 (75) | 75 (75) | 75 (75) | 75 (75) | |
| Patient 5 | 25 | 25 | 25 | 25 | 25 | |
| Patient 6 | 25 | 25 | 25 | 25 | 25 | |
| Patient 7 | 24 (24) | 25 | 25 | 25 | 25 | 25 |
| Control 1 | 24 | 24 | 25 | 25 | 25 | 24 |
| Control 2 | 25 | 25 | 25 | 25 | 25 | 25 |
| Control 3 | 25 | 25 | 25 | 25 | 25 | 25 |
| Control 4 | 23 (23) | 25 | 25 | 25 | 25 | 25 |
| Control 5 | 25 | 25 | 25 | 25 | 25 | 25 |
| Control 6 | 25 | 25 | 25 | 25 | 25 | 25 |
| Control 7 | 25 | 25 | 25 | 25 | 25 | 25 |
| Control 8 | 25 | 25 | 25 | 25 | 25 | 25 |
| Control 9 | 25 | 25 | 25 | 25 | 25 | 25 |
| Control 10 | 17 | 17 | 25 | 25 | 25 | 25 |
| Control 11 | 22 | 22 | 22 | 22 | 24 | 22 |
| Control 12 | 25 | 25 | 25 | 25 | 25 | 25 |
| Control 13 | 24 (24) | 25 | 25 | 25 | 25 | 25 |
| Control 14 | 24 | 24 | 25 | 25 | 25 | 25 |
| Control 15 | 25 | 25 | 25 | 25 | 25 | 25 |
| Control 16 | 24 | 24 | 25 | 25 | 24 | 23 |
| Control 17 | 25 | 25 | 24 | 25 | 25 | 25 |
| Control 18 | 25 | 25 | 25 | 25 | 25 | 25 |
| Control 19 | 24 | 24 | 25 | 25 | 25 | 25 |
| Control 20 | 25 | 25 | 25 | 25 | 25 | 25 |
| Control 21 | 22 (22) | 25 | 25 | 25 | 25 | 25 |
| Control 22 | 25 | 25 | 24 | 25 | 25 | 25 |
BEWG, foot movement locked to EMG; MFOT, foot movement locked to stimulus onset; MHND, hand movement; IFOT, foot movement imagination; IHND, hand movement imagination; REST, resting.
Figure 3Average ERPs of four healthy subjects recorded on Pz during foot movement execution. Segments are locked to EMG onset (time point 0) and artifacts had been excluded strictly. The x-axis displays time (ms) and the y-axis amplitudes (μV). Sections shaded in gray indicate significant differences from the resting condition on a single trial level with p <0.05.
Figure 4Average ERPs of two healthy subjects recorded on Pz during foot movement execution. Segments are based on stimulus onset (time point 0) and artifacts were excluded strictly. The x-axis displays time (ms) and the y-axis amplitudes (μV). Sections shaded in gray indicate significant differences from the resting condition on a single trial level with p < 0.05.
Figure 5ERPs of a single trial during the foot movement condition of patient 7. The upper figure depicts the response on Pz with regard to stimulus onset (time point 0) and the lower figure shows the EMG responses. The x-axes display time (ms) and the y-axes amplitudes (μV).
Figure 6Average ERPs of four healthy subjects after lenient exclusion recorded on Pz during foot movement execution. Segments are based on EMG onset (time point 0). The x-axis displays time (ms) and the y-axis amplitudes (μV). Sections shaded in gray indicate significant differences from the resting condition on a single trial level with p < 0.05.
Figure 7Average ERPs of patient 2 recorded on the electrode Pz during the foot (a) and hand (c) movement execution conditions and during the imagination of foot (b) and hand (d) movements. Conditions start at time 0. Segments are not corrected for artifacts. The x-axis displays time (ms) and the y-axis amplitudes (μV). Gray shading indicates significant differences from the resting condition on a single trial level with p < 0.05.